Promising New Developments in Spinal Non-fusion Treatment Will Push the Market to Almost $750 Million by 2021, says GlobalData
LONDON, UK (GlobalData), 17 December 2015 – The global market for spinal non-fusion treatments will expand from just under $521 million in 2014 to $749 million by 2021, at a Compound Annual Growth Rate (CAGR) of 5.3%, according to research and consulting firm GlobalData.
The company’s latest report* states that this moderate growth will be driven primarily by the promising Cervical Total Disc Replacement (C-TDR) segment, due to an increasing availability of clinical efficacy data, the rising prevalence of degenerative spine diseases and the industry’s aggressive efforts in relation to physician training and direct-to-consumer marketing.
According to Linda Tian, MSc, GlobalData’s Managing Analyst covering Medical Devices: “C-TDR is the fastest-growing segment in the spinal care market, as it has shifted from being considered an investigational surgery to a viable alternative to Anterior Cervical Discectomy and Fusion (ACDF).
“In general, using C-TDR in the right patients has been shown to reduce the rate of reoperations, deliver higher rates of clinical success, and reduce costs as compared to ACDF. Other growth drivers for C-TDR include improving reimbursement for the procedures in most major markets and an aging patient population that is more well-informed and demanding of motion preservation than ever before.”
Over the past decade, the number of C-TDR devices has proliferated and such products are now available in various shapes, materials, and biomechanical concepts.
Tian continues: “Despite the clear advantages opting for disc replacement non-fusion options can offer, its widespread adoption still faces barriers. Generally, large companies have avoided these technologies in light of stringent government and insurance company regulations. They seem to be more interested in acquiring the technology once it has been designed and approved.”
GlobalData’s report also states that an increase in mergers and acquisitions activity is a trend that is likely to persist over the next five years.
Tian adds: “Market-leading companies, such as DePuy Synthes and Medtronic, initially entered the non-fusion market through acquisitions. Since then, a league of small- to medium-sized companies have internally developed and marketed their artificial discs or other non-fusion technologies.
“Although DePuy is likely to dominate the spinal non-fusion arena during the forecast period, the artificial disc replacement market will continue to attract new entrants.”
NOTES TO EDITORS
This report provides analysis of the spinal non-fusion treatment space across the 10 major markets of the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India, including annualized market data from 2014 and forecast until 2021.
This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.
For guidelines on how to cite GlobalData, please see: http://www.globaldata.com/QuotingGlobalData.aspx
ABOUT GLOBALDATA
GlobalData is a leading global research and consulting firm offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.
For more information, please contact our Press Office on +44 (0)161 359 5822 or at pr@globaldata.com.
